The Discounted Cash Flow (DCF) valuation of Addex Therapeutics Ltd (ADXN.SW) is (1.98) CHF. With the latest stock price at 0.06 CHF, the upside of Addex Therapeutics Ltd based on DCF is -3677.3%.
Based on the latest price of 0.06 CHF and our DCF valuation, Addex Therapeutics Ltd (ADXN.SW) is a sell. selling ADXN.SW stocks now will result in a potential gain of 3677.3%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 4.4% - 5.9% | 5.2% |
| Long-term Growth Rate | 3.0% - 4.2% | 3.6% |
| Fair Price | (12.34) - (1.09) | (1.98) |
| Upside | -22369.8% - -2071.6% | -3677.3% |